EQRx
Biotechnology ResearchMassachusetts, United States201-500 Employees
Effective 11/09/23, EQRx., Inc. is now a wholly-owned subsidiary of Revolution Medicines (https://www.revmed.com/)
Insights
Market Consolidation Impact EQRx being acquired by Revolution Medicines presents an opportunity to explore cross-selling products and services to the combined customer base.
Investor Interest Surge Investor attention and investigations around EQRx's recent acquisition could be leveraged to showcase stability and growth potential to attract new investors.
Tech Stack Upgrade Utilizing EQRx's tech stack featuring advanced tools like TensorFlow presents an avenue to position the company as innovative and tech-savvy in discussions with potential clients.
Financial Health Assessment With a funding of $1.2B, EQRx's financial strength indicates capability for larger purchases, making them an attractive partner for high-value deals.
Competitive Analysis Advantage Comparing EQRx with similar companies like Skyhawk Therapeutics and Kymera Therapeutics can provide insights on positioning strategies and competitive advantages to target shared market segments.
Similar companies to EQRx
Skyhawk Therapeutics
$10M$50MKronos Bio
$10M$50MCorvidia Therapeutics
Syros Pharmaceuticals
$10M$50MKymera Therapeutics
$10M$50MFlagship Pioneering
$50M$100MRheos Medicines
Omega Therapeutics
$10M$50MGoldfinch Bio
$10MRelay Therapeutics
$10M$50MTango Therapeutics
$10M$50MCelsius Therapeutics
$10M
EQRx Tech Stack
EQRx uses 8 technology products and services including jsDelivr, ADP, Underscore.js, and more. Explore EQRx's tech stack below.
- jsDelivrContent Delivery Network
- ADPHuman Resource Management System
- Underscore.jsJavascript Libraries
- SlickJavascript Libraries
- TensorFlowMachine Learning
- C++Programming Languages
- JavaScriptProgramming Languages
- PerlProgramming Languages
Media & News
EQRx's Email Address Formats
EQRx uses at least 2 format(s):
| EQRx Email Formats | Percentage |
| FLast@eqrx.com | 94% |
| Last@eqrx.com | 4% |
| FMiddleLast@eqrx.com | 1% |
| FL@eqrx.com | 1% |
| FLast@revmed.com | 78% |
| First@revmed.com | 21% |
| Last@revmed.com | 1% |
Frequently Asked Questions
Where is EQRx's headquarters located?
EQRx's main headquarters is located at Cambridge, MA US. The company has employees across 4 continents, including North AmericaEuropeSouth America. What is EQRx's stock symbol?
EQRx is a publicly traded company; the company's stock symbol is EQRX. What is EQRx's official website and social media links?
EQRx's official website is revmed.com and has social profiles on LinkedIn.How much revenue does EQRx generate?
As of December 2023, EQRx's annual revenue reached $35M. What is EQRx's SIC code NAICS code?
EQRx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does EQRx have currently?
As of December 2023, EQRx has approximately 201 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: M. N.Chief Compliance And Risk Officer: C. C.Chief Financial Officer: J. R.. Explore EQRx's employee directory with LeadIQ.What technology does EQRx use?
EQRx's tech stack includes jsDelivrADPUnderscore.jsSlickTensorFlowC++JavaScriptPerl. What is EQRx's email format?
EQRx's email format typically follows the pattern of . Find more EQRx email formats with LeadIQ. How much funding has EQRx raised to date?
As of December 2023, EQRx has raised $1.2B in funding. The last funding round occurred on Dec 17, 2021 for $1.2B.When was EQRx founded?
EQRx was founded in 2019.
Company Overview
- Headquarters
- Cambridge, MA US
- Website
- revmed.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- EQRX
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2019
- Employees
- 201-500
Media & News
Funding & Financials
- $1.2B
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
- $10M$50M
EQRx's revenue is in the range of $10M$50M
Funding & Financials
- $1.2B
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
- $10M$50M
EQRx's revenue is in the range of $10M$50M
Company Leadership
M. N.Chief Executive Officer- C. C.Chief Compliance And Risk Officer
- J. R.Chief Financial Officer
K. R.Chief Customer Officer
R. A.Chief People Officer
Employee Directory
- K. R.Chief Customer Officer
- L. G.Founder And Partner
- P. M.Talent Acquistion Partner
- R. F.Co-Founder And Cxo
- R. A.Chief People Officer
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
